Panhematin 350 MG vials
Ended Awarded
- Contract number
- SPE2DB25FKEMX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,118
Award facts
- Contract value 100% obligated
- $15,117.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $15,117.92 to DMS Pharmaceutical Group Inc. for the supply of Panhematin 350 mg vials, with an ultimate completion date of October 20, 2025. This delivery order, issued on September 26, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the awardee under UEI PX72BSBQTKJ3. The place of performance is located in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The SPE2DB program vehicle enables DLA to issue firm fixed-price delivery orders for pharmaceutical products supporting military health facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides comprehensive distribution of branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites. The company's robust contract portfolio demonstrates consistent performance in delivering specialized pharmaceutical products, including oncology treatments, vaccines, and other critical medications essential to military medical operations.
Quick answers
Who was awarded contract SPE2DB25FKEMX?
SPE2DB25FKEMX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FKEMX worth?
The government has obligated $15,118 on SPE2DB25FKEMX.
Is contract SPE2DB25FKEMX an order under another contract?
Yes. SPE2DB25FKEMX is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEMX competed?
The extent of competition for SPE2DB25FKEMX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award